Group News
Completion of Acquisition
Dec 10, 2007
The Board of Avacta announces that, following the Annual
General Meeting of the Company held today, at which all resolutions were duly
passed, the conditional acquisition of Oxford Medical Diagnostics Limited
(“OMD”) announced on 14 November 2007 has been completed.
Application has been made for the 43,908,069 ordinary shares
of 0.1 pence each in the capital of Avacta (“Ordinary Shares”) issued as
consideration for the acquisition of OMD to be admitted to trading on AIM.
Dealings are expected to commence on [20] December 2007.
The Company’s issued ordinary share capital now comprises
822,386,111 Ordinary Shares.
Alastair Smith, Chief Executive of Avacta Group plc, said “I am very pleased indeed that Oxford Medical Diagnostics has joined the Avacta Group of companies. I see huge potential for OMD’s technology in the area of clinical breath diagnostics and a strong growth in short term revenue contribution to the Group from the industrial gas sensing market.”
Enquiries:
|
Avacta Group plc Alastair Smith, Chief Executive Officer Tim Sykes, Chief Financial Officer
|
Tel: 0870 835 4367 |
|
WH Ireland Limited David Youngman/Robin Gwyn
|
Tel: 0161 832 2174 |
|
Nexus Financial Limited Nicholas Nelson/Kathy Boate
|
Tel: 020 7451 7050 |